DANCR and neoplasm: In contrast, DANCR knockdown in colon cancer cells can directly interact with and increase the expression of miR-125b-5p, which targets hexokinase 2 (HK2), thus suppressing glycolysis and enhancing DDP sensitivity in tumour cells.